News

Actions

Warren Buffett diagnosed with prostate cancer

Warren Buffett diagnosed with prostate cancer
Posted at 6:39 PM, Apr 17, 2012
and last updated 2012-04-17 20:39:06-04

NEW YORK (CNNMoney) — Iconic investor Warren Buffett announced Tuesday that he has been diagnosed with stage I prostate cancer in a letter to shareholders of his firm Berkshire Hathaway.

Buffett, 81, said his “condition is not remotely life-threatening or even debilitating in any meaningful way,” and that additional tests didn’t reveal incidence of cancer anywhere else in his body.

“I feel great — as if I were in my normal excellent health — and my energy level is 100%,” wrote Buffett. “I will let shareholders know immediately should my health situation change. Eventually, of course, it will; but I believe that day is a long way off.”

Over 70% of men who are diagnosed with prostate cancer don’t die from the disease, according to Dr. Otis Brawley, a prostate cancer expert and the chief medical officer for the American Cancer Society.

“The 5-year survival rate for stage 1 prostate cancer is over 99%,” he said.

Given that Buffett’s cancer is in stage 1, the lowest stage, it has not spread to outside the prostate and has no yet spread to lymph nodes.

Dr. Brawley also said that about half of the men diagnosed annually with stage 1 prostate cancer are “actually overtreated” and likely don’t require any treatment at all.

Buffett said he will undergo daily radiation for two months beginning in mid-July, a decision made with his doctors.

While the treatment will restrict him from traveling during the period, Buffett said his daily routine will not otherwise change.

Buffett has made a name for himself by turning Berkshire Hathaway into a successful investment firm. Berkshire owns more than 80 companies, including insurer Geico, chemical company Lubrizol, railroad company Burlington Northern Santa Fe, and MidAmerican Energy.

The firm also boasts major investments in such companies such as Wells Fargo, IBM, and Bank of America.

Thanks to Buffett’s envied eye for value, Berkshire Hathaway has managed to handily beat the performance of the S&P 500, the best measure of the broad stock market, for 39 of the 47 years he’s been running the company, averaging nearly 20% annual growth.

Buffett has yet to name his successor as CEO of Berkshire, but told shareholders in February that the company’s board is “enthusiastic” about an individual, as well as “two superb back-up candidates.”

David Sokol, who has been with Berkshire for more than a decade, is widely cast as a leading candidate to take over as CEO. Greg Abel, who runs Berkshire’s MidAmerican Energy, could also be on the short list. Contenders also include Ajit Jain, who has run Berkshire’s highly profitable reinsurance business for 25 years, and Matt Rose, of Burlington Northern.

Buffett also said that two investment managers who recently joined the company, Todd Combs and Ted Weschler “will be handling a few billion dollars in 2012, but they have the brains, judgment and character to manage our entire portfolio” when he and Charlie Munger, Berkshire’s vice chairman, are no longer running the company.

Buffett’s son, Howard, is in line to follow as chairman of Berkshire Hathaway upon his father’s death. Howard will not, however, be involved in strategy or day-to-day decisions, the elder Buffett told CNNMoney in December.

Most recently, billionaire Buffett has been in the spotlight as Washington lawmakers consider comprehensive tax reform.

President Obama has been touting the Buffett Rule, which proposes that millionaires and billionaires like Buffett shouldn’t pay a lower percentage of their income in federal taxes than middle-class households. Rather, it says they should pay at least 30% of their income.

A proposal to implement the Buffett Rule was blocked in the Senate on Monday, but proponents of the millionaire tax vowed to keep the issue alive in the months ahead.

Shares of Berkshire Hathaway slipped 1.5% in after-hours trading Tuesday, following the release of the shareholder letter.

— CNN Medical Managing Editor Miriam Falco contributed to this report.

The-CNN-Wire/Atlanta/+1-404-827-WIRE(9473)
™ & © 2012 Cable News Network, Inc., a Time Warner Company. All rights reserved.